Summary
The kinds of microorganisms isolated from the wounds of burn patients from 1964–1988 are presented and their association with infections and septic deaths in this patient population is reviewed. Procedures for testing of antimicrobial creams and solutions for topical use in burn wound care are presented and data resulting from these types of assays are discussed. A brief discussion of the pros and cons of quantitative microbial wound culture is presented as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alford RH, Hall A. Epidemiology of infections caused by gentamincin-resistant enterobacteriaceae and Pseudomonasaeruginosa over 15 years at the Nashville Veterans Administration Medical Center. Rev Infect Dis 9: 1079–1086, 1987.
Arnow PM, Allyn PA, Nichols, M, Hill DI, Pezzlo M, Bartlett PH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 22: 954–959, 1982.
Ayliffe GAJ, Green W, Livingston R. Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J Clin Path 30: 40–44, 1977.
Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of Methidllin-resistant Staphylococcus aureus infections. JAMA 249: 2803–2807, 1983.
Bruck HM, Nash G, Pruitt BS, Jr. Opportunistic fungal infection of the burn wound with phycomycetes and Aspergillus. Arch Surg 102: 476–481, 1972.
Cason KS, Lowbury EJ. Mortality and infection in extensively burned patients treated with silver nitrate compresses. Lancet 1: 651, 1968.
Cruickshank R. The bacterial infection of burns. J Path 41: 367, 1935.
Everett, ED, McNitt TR, Rahm AE. Epidemiologic investigation of methicillin-resistant Staphylococcus aure-us in a burn unit. Milit Med 143: 165–167, 1978.
Heggers JP, Velanovich V, Robson MC, Zoellner SM, Schileru R, Boertman J, Xing-Tao N. Control of burn wound sepsis: a comparison of in vitro topical antimicrobial assays. J Trauma 27: 176–179, 1987.
Henjyoji EY. Bacteremia due to Serratia marcescens. J Trauma 11: 417–419, 1971.
Holder IA. Gentamidn resistant Pseudomonasaeruginosa in a burns unit. J Antimicrob Chemother 2: 309–316, 1976.
Holder IA. The pathogenesis of infections owing to Pseudomonasaeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati. Can J Microbiol 31: 393–402, 1985.
Holder IA. The wet disc antimicrobial solution assay: an invitro method to test efficacy of antimicrobial solutions for topical use. J Burn Care Rehab 10: 203–208, 1989.
Holder IA, Schwab M, Jackson L. Eighteen months of routine topical; antimicrobial susceptibility testing of isolates from burnpatients: results and conclusions. J An timicrob Chemother 5: 455–463, 1979.
Kagan RJ, Naraqi S, Matsuda T, Jonasson OM. Herpes simplex virus and cytomegalovirus infections in burned patients. J Trauma 25: 40–45, 1985.
Kim HS, Hubbard GB, Worley BL, McManus WF, Mason AD, Pruitt BA. A rapid section technique for burn wound biopsy. J Burn Care Rehab 6: 433–435, 1985.
Langhor J, Owen C, Cope O. Bacteriologic study of burn wounds. Ann Surg 125: 452–457, 1947.
Law EJ, Holder IA, McMillan BG. Candida parapsilosis fungemia in burn patients: report of three cases. Burns: 10: 203–206, 1983.
LeFrock JL, Molavi A, Smith BR. Current use of aminoglycosides. Infect Surg 3: 57–65, 1984.
Levine MS, Lindberg RB, Mason AD. The quantitative swab culture and smear: a quick simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 16: 89–94, 1976.
Linnemann CC, MacMillan BG. Viral infections in pediatric burn patients. Am J Dis Child 135: 750–753, 1981.
Loebl EC, Marvin JA, Heck EL. The method of quantitative burn-wound biopsy cultures and its routine use in the care of the burned patient. Am J Clin Path 61: 20–24, 1974.
Lorenti AS, Carbonell-Bensadon JM, Benaim F. Sensibility assay for topical agents. J Burn Care Rehab 10: 209–212, 1989.
Lynch JB, et al. Changing patterns of mortality in burns. Plast Reconstr Surg 48: 329–332, 1971.
MacMillan BG. Ecology of bacteria colonizing the burned patient given topical and systemic gentamidn therapy: A five-year study. J Infect Dis 124: 5278–5286, 1971
Maley MP. Methidllin-resistant Staphylococcus aureus. Lancet 605, 1985.
Mangus DJ, Fox D, Gilchrist D, Womack B, Ost J. Quantitative evaluation and laboratory studies of topical antibiotic therapy in burns. J Burn Care Rehab 6: 39–46, 1985.
Mayhall CG, Polk RE, Haynes BW. Infections in burned patients. Infect Control 4: 454–459, 1983.
Mitchell V, Galizia JP, Fournier L. Precise diagnosis of infection in burn wound biopsy specimens. J Burn Care Rehab 10: 195–202, 1999.
Modak SM, Fox CL. Sulfadiazine silver-resistant Pseudomonas in burns. Arch Surg 116: 854–857, 1981.
Moyer CA, Brentano L, Cravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5 percent silver nitrate solution. Arch Surg 90: 812–867, 1965.
Murphy RC, Kucan JO, Robson MC, Heggers JP. The effect of 5 percent Mafenide acetate solution of bacterial control in infected rat burns. J Trauma 23: 878–881, 1983.
Nathan P, Holder IA, MacMillan B. Burn wounds: Microbiology, local host defenses and current therapy. Crit Rev Clin Lab Sci 4: 61–100, 1973.
Nathan P, Law EJ, Murphy DF, MacMillan BG. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns 4: 177–187, 1978.
Neal GD, Lindholm GF, Lee MJ. Burn wound histologic culture: a new technique for predicting burn wound sepsis. J Bum Care Rehab 2: 35–39, 1981.
Pruitt BA. Treating burn and soft tissue infections. Infect Surg 2: 625–650, 1983.
Rodheaver GT, Gentry S, Saffer L, Edlich RF. Topical antimicrobial cream sensitivity testing. Surg Gynecol Obstet 151: 747–752, 1980.
Saymen DG, Nathan P, Holder IA, Hill EO, MacMillan BG. Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol 23: 509–514, 1972.
Shuck JM, Einfeldt LE, Trainor MP. Sulfamylon solution dressings in the management of burn wounds: preliminary clinical report. J Trauma 12: 999–1002, 1972.
Spebar MJ, Walters MI, Pruitt BA, Jr. Improved survival with aggressive surgical management of noncandidal fungal infections of the burn wound. J Trauma 33: 867–868, 1982.
Speller DCE, Raghunath D, Stephens M. Epidemic infection by a gentamicin-resistant Staphylococcus aureua in three hospitals. Lancet 1: 464–466, 1976.
Stieritz D, Law E, Holder IA. Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients. J Clin Path 26: 405, 1973.
Teplitz C, Davis D, Mason AD Jr. Pseudomonas burn wound sepsis. I. Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res 1: 200–216, 1964.
Waisbren BA. Treatment of severe burns. Comp Therapy 2: 33–42, 1976.
Wickman K. Studies on burns. XIV. Bacteriology. II. Acta Chir Scand suppl 408: 1–34, 1970.
Woolfrey BF, Fox JM, Quail CD. An evaluation of burn wound quantitative microbiology. I. Quantitative es-char cultures. Am J Clin Path 75: 532–537, 1981.
Woolfrey BF, Fox JMK, Quall CO. An evaluation of burn wound microbiology: the quantitative gram stain. J Burn Care Rehab 3: 171–175, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this chapter
Cite this chapter
Holder, I.A. (1990). Microbiology of the Burn Compromised Patient. In: Wadström, T., Eliasson, I., Holder, I., Ljungh, Å. (eds) Pathogenesis of Wound and Biomaterial-Associated Infections. Springer, London. https://doi.org/10.1007/978-1-4471-3454-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3454-1_11
Publisher Name: Springer, London
Print ISBN: 978-3-540-19596-2
Online ISBN: 978-1-4471-3454-1
eBook Packages: Springer Book Archive